256 related articles for article (PubMed ID: 37582820)
41. Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.
Yuan P; Huang S; Bao FC; Cao JL; Sheng HX; Shi L; Lv W; Hu J
Eur J Cancer; 2019 Oct; 120():10-19. PubMed ID: 31446212
[TBL] [Abstract][Full Text] [Related]
42. Myeloperoxidase G463A polymorphism and risk of lung cancer.
Li J; Fu Y; Zhao B; Xiao Y; Chen R
Tumour Biol; 2014 Jan; 35(1):821-9. PubMed ID: 23979979
[TBL] [Abstract][Full Text] [Related]
43. CYP3A4 genetic variants are associated with susceptibility of non-small cell lung cancer in a Shaanxi Han population.
Jia Z; Zhou W; Zhang G; Fu J; Li D; Ren L
Genomics; 2020 Sep; 112(5):3465-3472. PubMed ID: 32464168
[TBL] [Abstract][Full Text] [Related]
44. LncRNA NEAT1 polymorphisms and lung cancer susceptibility in a Chinese Northeast Han Population: A case-control study.
Wang S; Cui Z; Li H; Li J; Lv X; Yang Z; Gao M; Bi Y; Zhang Z; Zhou B; Yin Z
Pathol Res Pract; 2019 Dec; 215(12):152723. PubMed ID: 31704150
[TBL] [Abstract][Full Text] [Related]
45. Association between single nucleotide polymorphism of PD-L1 gene and non-small cell lung cancer susceptibility in a Chinese population.
Chen YB; Mu CY; Chen C; Huang JA
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e1-6. PubMed ID: 23167931
[TBL] [Abstract][Full Text] [Related]
46. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
Yu H; Pang Z; Li G; Gu T
J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
[TBL] [Abstract][Full Text] [Related]
47. The association between TP53 Arg72Pro polymorphism and lung cancer susceptibility: evidence from 30,038 subjects.
Qiao Q; Hu W
Lung; 2013 Aug; 191(4):369-77. PubMed ID: 23595658
[TBL] [Abstract][Full Text] [Related]
48. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
49. Telomere reverse transcriptase (TERT) rs2735940 increases cancer risk.
Yang H; Li J; Tang R; Liu Y; Shao Y; Huang Q; Shi J
Med Sci Monit; 2015 Feb; 21():612-6. PubMed ID: 25716168
[TBL] [Abstract][Full Text] [Related]
50. Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population.
Jin G; Xu L; Shu Y; Tian T; Liang J; Xu Y; Wang F; Chen J; Dai J; Hu Z; Shen H
Carcinogenesis; 2009 Jun; 30(6):987-90. PubMed ID: 19369581
[TBL] [Abstract][Full Text] [Related]
51. The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma.
Yuan X; Cheng G; Yu J; Zheng S; Sun C; Sun Q; Li K; Lin Z; Liu T; Li P; Xu Y; Kong F; Bjorkholm M; Xu D
Oncotarget; 2017 Apr; 8(14):23120-23129. PubMed ID: 28416747
[TBL] [Abstract][Full Text] [Related]
52. COX-2 rs5275 and rs689466 polymorphism and risk of lung cancer: A PRISMA-compliant meta-analysis.
Li J; Lu X; Zou X; Jiang Y; Yao J; Liu H; Ni B; Ma H
Medicine (Baltimore); 2018 Aug; 97(35):e11859. PubMed ID: 30170377
[TBL] [Abstract][Full Text] [Related]
53. Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100.
Krahling T; Balassa K; Kiss KP; Bors A; Batai A; Halm G; Egyed M; Fekete S; Remenyi P; Masszi T; Tordai A; Andrikovics H
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):98-104. PubMed ID: 26487696
[TBL] [Abstract][Full Text] [Related]
54. Allele and Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Lung Cancer in ther Jordanian Population: a Case Control Study.
Al-Motassem Y; Shomaf M; Said I; Berger S; Ababneh N; Diab O; Obeidat N; Awidi A
Asian Pac J Cancer Prev; 2015; 16(8):3101-9. PubMed ID: 25921104
[TBL] [Abstract][Full Text] [Related]
55. The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma.
Ma R; Liu C; Lu M; Yuan X; Cheng G; Kong F; Lu J; Strååt K; Björkholm M; Ma L; Xu D
Urol Oncol; 2019 May; 37(5):301.e1-301.e10. PubMed ID: 30738744
[TBL] [Abstract][Full Text] [Related]
56. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y
BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123
[TBL] [Abstract][Full Text] [Related]
57. Certain interleukin polymorphisms might influence predisposition to lung cancer: A meta-analysis of 35 published studies.
Gao J; Ying Y; Wang J; Cui Y; Zhang W
IUBMB Life; 2020 May; 72(5):957-964. PubMed ID: 32077194
[TBL] [Abstract][Full Text] [Related]
58. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis.
Mocellin S; Verdi D; Pooley KA; Landi MT; Egan KM; Baird DM; Prescott J; De Vivo I; Nitti D
J Natl Cancer Inst; 2012 Jun; 104(11):840-54. PubMed ID: 22523397
[TBL] [Abstract][Full Text] [Related]
59. Potential Impacts of
Lee KL; Lai TC; Wang YC; Shih PC; Yang YC; Tsao TC; Liu TC; Wen YC; Chang LC; Yang SF; Chien MH
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33802737
[TBL] [Abstract][Full Text] [Related]
60. Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in a Chinese population.
Zhao MM; Zhang Y; Shen L; Ren YW; Li XL; Yin ZH; Zhou BS
Asian Pac J Cancer Prev; 2014; 15(6):2809-13. PubMed ID: 24761905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
